INARI MEDICAL INC (NARI) Institutional Ownership
None of the superinvestors we track currently report INARI MEDICAL INC (NARI) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in INARI MEDICAL INC (NARI), this page will show 13F-reported ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q4 2024 | 1 | $9,934,279 | 194,599 |
| Q3 2024 | 1 | $9,604,755 | 232,899 |
| Q2 2024 | 1 | $3,794,172 | 78,799 |
| Q1 2024 | 1 | $6,266 | 130,599 |
| Q4 2023 | 1 | $9,102 | 140,199 |
| Q3 2023 | 1 | $25,316 | 387,099 |
| Q2 2023 | 1 | $32,372 | 556,799 |
| Q1 2023 | 1 | $32,751 | 530,462 |
| Q4 2022 | 1 | $13,818 | 217,399 |
| Q3 2022 | 1 | $3,276 | 45,099 |
| Q2 2022 | 1 | $13,210 | 194,299 |
| Q1 2022 | 1 | $8,565 | 94,499 |
Related NARI Institutional Insights:
- NARI Institutional Ownership & Insiders Activity
- NARI Institutional Ownership & 13F Activity
- NARI Top Institutional Shareholders
- NARI Institutional Buying Activity
- NARI Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- NARI Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings